Innovations are expanding the number of people who can benefit from continuous glucose monitoring and a recent move by ...

Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $99.82, along ...

Outgoing CEO Kevin Sayer expects expanding coverage of Dexcom’s glucose sensors for people with Type 2 diabetes and ...

SAN DIEGO - Dexcom reported revenue growth of 15% year-over-year to $1.157 billion for the second quarter of 2025.

After taking on the title of president earlier this year, Dexcom’s Jake Leach will be stepping into the role of CEO at the ...

DexCom, Inc. (DXCM - Free Report) reported second-quarter 2025 adjusted earnings per share (EPS) of 48 cents, which beat the ...

Dexcom ( ($DXCM) ) has released its Q2 earnings. Here is a breakdown of the information Dexcom presented to its investors. Dexcom, Inc., a leader ...

DexCom reports 15% Q2 2025 revenue growth, boosted by expanded type 2 diabetes access & product innovation. Discover their raised outlook & future plans.

Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on ...

Jake Leach will take over the role at the start of 2026, with Sayer remaining chairman of the board after the transition.